TrialBMC nephrology2019

Efficacy and safety of sodium zirconium cyclosilicate in patients with baseline serum potassium level ≥ 5.5 mmol/L: pooled analysis from two phase 3 trials.

Alpesh N Amin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.